{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T14:23:06Z","timestamp":1699971786961},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.ijpharm.2005.03.014","type":"journal-article","created":{"date-parts":[[2005,5,12]],"date-time":"2005-05-12T11:45:15Z","timestamp":1115898315000},"page":"38-46","source":"Crossref","is-referenced-by-count":7,"title":["Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous torasemide in rats"],"prefix":"10.1016","volume":"298","author":[{"given":"Dae Y.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myung G.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2005.03.014_bib1","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1016\/0006-2952(87)90450-3","article-title":"Studies on the pregnenolone-16-carbonitrile-inducible form of rat liver microsomal cytochrome P-450 and UDP-glucuronosyl transferase","volume":"36","author":"Arlotto","year":"1987","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijpharm.2005.03.014_bib2","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1002\/jps.20151","article-title":"Effects of cysteine on the pharmacokinetics of intravenous torasemide in rats with protein\u2013calorie malnutrition","volume":"93","author":"Bae","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2005.03.014_bib3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/BF01062108","article-title":"Critical evaluation of the potential error in pharmacokinetic studies using the linear trapezoidal rule method for the calculation of the area under the plasma level\u2013time curve","volume":"6","author":"Chiou","year":"1978","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.ijpharm.2005.03.014_bib4","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/jps.2600680843","article-title":"New calculation method for mean apparent drug volume of distribution and application to rational dosage regimen","volume":"68","author":"Chiou","year":"1979","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2005.03.014_bib5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/jps.2600690125","article-title":"New calculation method of mean total body clearance of drugs and its application to rational dosage regimens","volume":"69","author":"Chiou","year":"1980","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2005.03.014_bib6","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1006\/abbi.1999.1482","article-title":"Suppression of rat hepatic cytochrome P450s by protein\u2013calorie malnutrition: Complete or partial restoration by cysteine or methionine supplementation","volume":"372","author":"Cho","year":"1999","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ijpharm.2005.03.014_bib7","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/jps.2600800705","article-title":"Effect of phenobarbital and 3-methylcholanthrene pretreatment on the pharmacokinetics and pharmacodynamics of furosemide in rats","volume":"80","author":"Choi","year":"1991","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2005.03.014_bib8","series-title":"Fundamentals of Drug Metabolism and Drug Disposition","first-page":"269","article-title":"Environmental factors influencing drug metabolism","author":"Conney","year":"1971"},{"key":"10.1016\/j.ijpharm.2005.03.014_bib9","series-title":"Cytochrome P450. Structure, Mechanism, and Biochemistry","first-page":"607","article-title":"Appendix B. Rat and human liver cytochromes P450. Substrate and inhibitor specificities and functional markers","author":"Correia","year":"1995"},{"key":"10.1016\/j.ijpharm.2005.03.014_bib10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1124\/mol.64.1.160","article-title":"Colchicine down-regulates cytochrome P450 2B6, 2C8, 2C9, and 3A4 in human hepatocytes by affecting their glucocorticoid receptor-mediated regulation","volume":"64","author":"Dvorak","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ijpharm.2005.03.014_bib11","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF01061729","article-title":"Pharmacokinetics of diazepam following multiple dose oral administration to healthy human subjects","volume":"5","author":"Eatman","year":"1977","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.ijpharm.2005.03.014_bib12","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1078\/094471103322004839","article-title":"In vitro inhibition of human cytochrome P450-mediated metabolism of marker substrates by natural products","volume":"10","author":"Foster","year":"2003","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ijpharm.2005.03.014_bib13","first-page":"242","article-title":"Induction of CYP2C genes in human hepatocytes in primary culture","volume":"29","author":"Gerbal-Chaloin","year":"2001","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijpharm.2005.03.014_bib14","series-title":"Pharmacokinetics","author":"Gibaldi","year":"1982"},{"key":"10.1016\/j.ijpharm.2005.03.014_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0003-9861(88)90613-3","article-title":"Multiplicity of steroid-inducible cytochrome P-450 in rat liver microsomes","volume":"263","author":"Halpert","year":"1988","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ijpharm.2005.03.014_bib16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0300-483X(96)03604-9","article-title":"Involvement of cytochrome P450 2E1 in the toxicity of dichloropropanol to rat hepatocyte cultures","volume":"118","author":"Hammond","year":"1997","journal-title":"Toxicology"},{"key":"10.1016\/j.ijpharm.2005.03.014_bib17","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1006\/bbrc.1999.1544","article-title":"Phosphorylation\/dephosphorylation steps are crucial for the induction of CYP2B1 and CYP2B2 gene expression by phenobarbital","volume":"264","author":"Kawamura","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijpharm.2005.03.014_bib18","unstructured":"Kim, Y.C., 2005. Pharmacokinetic changes of drugs in rats with diabetes mellitus with respect to CYP isozymes changes. Ph.D. Thesis, Seoul National University, Seoul, Korea."},{"key":"10.1016\/j.ijpharm.2005.03.014_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/bdd.333","article-title":"Pharmacokinetics and pharmacodynamics of intravenous torasemide in mutant Nagase analbuminemic rats","volume":"24","author":"Kim","year":"2003","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ijpharm.2005.03.014_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01061772","article-title":"Pharmacokinetics and pharmacodynamics of furosemide in protein\u2013calorie malnutrition","volume":"21","author":"Kim","year":"1993","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.ijpharm.2005.03.014_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-199834010-00001","article-title":"Clinical pharmacokinetics and pharmacodynamics of torasemide","volume":"34","author":"Knauf","year":"1998","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ijpharm.2005.03.014_bib22","doi-asserted-by":"crossref","unstructured":"Lee, D.Y., Kim, J.Y., Kim, Y.C., Kwon, J.W., Kim, W.B., Lee, M.G. Dose-independent pharmacokinetics of torasemide after intravenous and oral administration to rats. Biopharm. Drug Dispos., in press.","DOI":"10.1002\/bdd.447"},{"key":"10.1016\/j.ijpharm.2005.03.014_bib23","series-title":"Cytochromes P450 Structure, Function and Mechanism","article-title":"P450 substrate specificity and metabolism","author":"Lewis","year":"1996"},{"key":"10.1016\/j.ijpharm.2005.03.014_bib24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0003-9861(92)90107-8","article-title":"Constitutive expression and hormonal regulation of male sexually differentiated cytochrome P450 in primary cultured rat hepatocytes","volume":"298","author":"Liddle","year":"1992","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ijpharm.2005.03.014_bib25","first-page":"1076","article-title":"Human hepatic cytochrome P450 2C9 catlayzes the rate-limiting pathway of torasemide metabolism","volume":"272","author":"Miners","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijpharm.2005.03.014_bib26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0006-2952(94)90013-2","article-title":"Trimethadione metabolism, a useful indicator for assessing hepatic drug-oxidizing capacity","volume":"47","author":"Nakamura","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijpharm.2005.03.014_bib27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1248\/bpb.22.191","article-title":"Pharmacokinetic drug interactions between ampiroxicam and sulfaphenazole in rats","volume":"22","author":"Ogiso","year":"1999","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ijpharm.2005.03.014_bib28","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/0006-2952(93)90195-3","article-title":"Formation of ligand and metabolite complexes as a means for selective quantitation of cytochrome P450 isozymes","volume":"45","author":"Ross","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijpharm.2005.03.014_bib29","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.1016\/S0021-9258(18)88984-0","article-title":"Characterization of a major form of rat hepatic microsomal cytochrome P-450 induced by isoniazid","volume":"260","author":"Ryan","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpharm.2005.03.014_bib30","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00003088-200140040-00003","article-title":"Clinical pharmacokinetics of fluvastatin","volume":"40","author":"Scripture","year":"2001","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ijpharm.2005.03.014_bib31","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0006-2952(99)00349-4","article-title":"Acetaminophen hepatotoxicity precipitated by short-term treatment of rats with ethanol and isopentanol: Protection by triacetyloleandomycin","volume":"59","author":"Sinclair","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijpharm.2005.03.014_bib32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1034\/j.1600-0773.2000.d01-14.x","article-title":"Differential activities of CYP1A isozymes in hepatic and intestinal microsomes of control and 3-methylcholanthrene-induced rats","volume":"86","author":"Spatzenegger","year":"2000","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.ijpharm.2005.03.014_bib33","first-page":"1374","article-title":"Effects of cytochrome P450 2D1 inhibition on hydrocodone metabolism and its behavioral consequences in rats","volume":"280","author":"Tomkins","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijpharm.2005.03.014_bib34","first-page":"924","article-title":"Characterization of cytochrome P-450 2D1 activity in rat brain: High-affinity kinetics for dextromethorphan","volume":"27","author":"Tyndale","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijpharm.2005.03.014_bib35","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1002\/rcm.1621","article-title":"Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography\/mass spectrometry and automated online extraction","volume":"18","author":"Unger","year":"2004","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.ijpharm.2005.03.014_bib36","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/0006-2952(79)90589-6","article-title":"Effect of phenobarbital and 3-methylcholanthrene pretreatment on the plasma half-life and urinary excretion profile of theophylline and its metabolites in rats","volume":"28","author":"Williams","year":"1979","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijpharm.2005.03.014_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-199100413-00003","article-title":"How do loop diuretics act?","volume":"41","author":"Wittner","year":"1991","journal-title":"Drugs"},{"key":"10.1016\/j.ijpharm.2005.03.014_bib38","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1021\/bi00330a010","article-title":"Identification of the cytochrome P-450 induced by macrolide antibiotics in rat livers as the glucocorticoid responsive cytochrome P450p","volume":"24","author":"Wrighton","year":"1985","journal-title":"Biochemistry"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517305001961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517305001961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T22:16:39Z","timestamp":1625955399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517305001961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0378517305001961"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2005.03.014","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}